Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-12-000210
Filing Date
2012-05-15
Accepted
2012-05-15 15:34:42
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10Q cellcyteform10qmarch312012v4.htm 10-Q 235928
2 CERTIFICATION exhibit31.htm EX-31 12522
3 CERTIFICATION exhibit32.htm EX-32 5045
  Complete submission text file 0001056520-12-000210.txt   1381992

Data Files

Seq Description Document Type Size
4 INSTANCE ccyg-20120331.xml EX-101.INS 147155
5 SCHEMA ccyg-20120331.xsd EX-101.SCH 7106
6 CALCULATION ccyg-20120331_cal.xml EX-101.CAL 4524
7 DEFINITION ccyg-20120331_def.xml EX-101.DEF 5343
8 LABELS ccyg-20120331_lab.xml EX-101.LAB 80486
9 PRESENTATION ccyg-20120331_pre.xml EX-101.PRE 61319
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 12844137
SIC: 2834 Pharmaceutical Preparations